Literature DB >> 9675058

Secretory expression of human albumin domains in Saccharomyces cerevisiae and their binding of myristic acid and an acylated insulin analogue.

T Kjeldsen1, A F Pettersson, L Drube, P Kurtzhals, I Jonassen, S Havelund, P H Hansen, J Markussen.   

Abstract

Albumin is organized in three homologous domains formed by double loops stabilized by disulfide bonds. Utilizing a secretory expression system based on a synthetic secretory prepro-leader, the three human serum albumin domains were expressed in the yeast Saccharomyces cerevisiae. Human serum albumin domains I and III were efficiently expressed and secreted, indicating that these domains can form independent structural units capable of folding into stable tertiary structures. In contrast, albumin domain II was not secreted and disappeared early in the secretory pathway. Human serum albumin has the ability to bind a large number of small molecule ligands, including fatty acids, presumably due to its structure and structural flexibility. Purified albumin domain III bound myristic acid, whereas purified albumin domain I did not bind myristic acid. A new soluble long-acting insulin an alogue acylated with myristic acid (Markussen J., et al., Diabetologia 39, 281-288, 1996) bound to domain III and bound markedly more weakly to domain I. Copyright 1998 Academic Press.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9675058     DOI: 10.1006/prep.1998.0876

Source DB:  PubMed          Journal:  Protein Expr Purif        ISSN: 1046-5928            Impact factor:   1.650


  3 in total

1.  Functional analysis of recombinant human serum albumin domains for pharmaceutical applications.

Authors:  Sadaharu Matsushita; Yu Isima; Victor Tuan Giam Chuang; Hiroshi Watanabe; Sumio Tanase; Tomu Maruyama; Masaki Otagiri
Journal:  Pharm Res       Date:  2004-10       Impact factor: 4.200

Review 2.  Insulin detemir: a review of its use in the management of type 1 and 2 diabetes mellitus.

Authors:  Therese M Chapman; Caroline M Perry
Journal:  Drugs       Date:  2004       Impact factor: 9.546

3.  Different expression systems for production of recombinant proteins in Saccharomyces cerevisiae.

Authors:  Zihe Liu; Keith E J Tyo; José L Martínez; Dina Petranovic; Jens Nielsen
Journal:  Biotechnol Bioeng       Date:  2012-01-17       Impact factor: 4.530

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.